Light Mode
$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, $0.0349 below the day’s high of $0.0350
+0.00 (+0.00%) / 6M
Momentum, market sentiment, and recent alerts
VAXX reads poor: price sits below both the 20- and 200-day averages.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimer’s, Parkinson’s, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Exploration Park, FL.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
